483
Steri-Med Pharma Inc.Steri-Med Pharma Inc. – FDA 483, Feb 27, 2024
Record Details
An FDA inspection of Steri-Med Pharma Inc., a sterile manufacturer in Upton, revealed significant deficiencies in aseptic processing areas. The firm's airflow visualization studies for its aseptic filling line were inadequate, showing turbulent and eddying smoke patterns. Additionally, there was a lack of proper studies and monitoring to ensure a storage cart did not disrupt airflow in critical Grade A and B areas.
View Company Profile
ID · eb8cc7a6-9f52-4ee2-80f2-6ccad5913047
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.